DaVita
The Dialysis Certified Patient Care Technician provides direct, hands-on hemodialysis care to residents in a skilled nursing facility setting, partnering with a dedicated Registered Nurse to ensure safe and comfortable treatments. The role involves performing sterile cannulation, monitoring vital signs, operating Fresenius hemodialysis machines, and maintaining water treatment systems within an autonomous 6-chair dialysis den. This position offers a predictable 3-day work week with no on-call duties or Sunday treatments, focusing on building long-term relationships with a consistent group of patients.
Headquarters
Denver, Colorado, United States
Company Size
10001+ employees
Founded
1999
DaVita is a leading provider of kidney care services, offering dialysis treatments (in-center and home-based), chronic kidney disease education, and integrated care support for patients managing CKD and end-stage kidney disease. The company operates dialysis centers nationwide and provides tools and resources including dietitian-developed recipes, GFR calculators, and kidney health classes. DaVita also partners with hospitals, health plans, and skilled nursing facilities to deliver comprehensive kidney care solutions.
DaVita's kidney care program delivered $200M in savings as quality improved
19 hours ago
DaVita reports progress in value-based kidney care programs
19 hours ago
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
24 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for DaVita.
DaVita didn’t post a salary, so this is our estimate from similar listings.
DaVita Inc Stock (ISIN: US23804L1035) Gains on Value-Based Care Progress Amid Institutional Selling
5 hours ago